{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:21:09Z","timestamp":1792819269079,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ajem.2021.11.003","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T11:01:46Z","timestamp":1636455706000},"page":"296-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients"],"prefix":"10.1016","volume":"51","author":[{"given":"Kavita","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis B.","family":"Wassermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tednes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Bonderski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2021.11.003_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","author":"Singer","year":"2016","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.ajem.2021.11.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1097\/MEJ.0000000000000460","article-title":"Sepsis patients in the emergency department: stratification using the clinical impression score, predisposition, infection, response and organ dysfunction score or quick sequential organ failure assessment score?","author":"Quinten","year":"2018","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0015","series-title":"National hospital ambulatory medical care survey: 2017 emergency department summary tables","first-page":"37","author":"Rui","year":"2017"},{"issue":"11","key":"10.1016\/j.ajem.2021.11.003_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000005357","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1586\/eri.12.50","article-title":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes","author":"Martin","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"10.1016\/j.ajem.2021.11.003_bb0035","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","article-title":"Hydrocortisone, Vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study","volume":"151","author":"PE M, V K, R R, MH H, J C","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ajem.2021.11.003_bb0040","doi-asserted-by":"crossref","DOI":"10.2147\/OAEM.S166086","article-title":"Septic shock in the ER: diagnostic and management challenges","author":"Worapratya","year":"2019","journal-title":"Open Access Emerg Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.107.728840","article-title":"Inotropes and vasopressors:review of physiology and clinical use in cardiovascular disease","author":"Overgaard","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2021.11.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-018-5242-5","article-title":"A global perspective on vasoactive agents in shock","author":"Annane","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/1060028016682030","article-title":"Impact of norepinephrine weight-based dosing compared with non\u2013weight-based dosing in achieving time to goal mean arterial pressure in obese patients with septic shock","author":"Vadiei","year":"2017","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajem.2021.11.003_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.iccn.2017.02.003","article-title":"Evaluating the impact of obesity on safety and efficacy of weight-based norepinephrine dosing in septic shock: a single-center, retrospective study","author":"Wong","year":"2017","journal-title":"Intensive Crit Care Nurs"},{"key":"10.1016\/j.ajem.2021.11.003_bb0065","doi-asserted-by":"crossref","DOI":"10.4037\/ajcc2016667","article-title":"Norepinephrine dosing in obese and nonobese patients with septic shock","author":"Radosevich","year":"2016","journal-title":"Am J Crit Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","author":"Brown","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ajem.2021.11.003_bb0075","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000004476","article-title":"Evaluation of vasopressor exposure and mortality in patients with septic shock","author":"Roberts","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial","author":"Laterre","year":"2019","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.ajem.2021.11.003_bb0085","article-title":"Vasopressin and its role in critical care. Contin Educ Anaesthesia","author":"Sharman","year":"2008","journal-title":"Crit Care Pain"},{"key":"10.1016\/j.ajem.2021.11.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2005.07.076","article-title":"Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction","author":"Jolly","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajem.2021.11.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","author":"Gordon","year":"2016","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.ajem.2021.11.003_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/00003246-200208000-00038","article-title":"Skin necrosis after extravasation of low-dose vasopressin administered for septic shock","author":"Kahn","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-018-0379-5","article-title":"Predictors of response to fixed-dose vasopressin in adult patients with septic shock","author":"Sacha","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/phar.2346","article-title":"Vasopressin plasma concentrations are not associated with hemodynamic response to exogenous vasopressin for septic shock","author":"Yerke","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ajem.2021.11.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2016.08.010","article-title":"The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials","author":"Belletti","year":"2017","journal-title":"J Crit Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial","author":"Annane","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2021.11.003_bb0130","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000000807","article-title":"Angiotensin II in refractory septic shock","author":"Antonucci","year":"2017","journal-title":"Shock"},{"key":"10.1016\/j.ajem.2021.11.003_bb0135","article-title":"A retrospective review of angiotensin II use in adult patients with refractory distributive shock","author":"Wong","year":"2019","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2019.09.014","article-title":"Angiotensin II: a new vasopressor for the treatment of distributive shock","author":"Allen","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.ajem.2021.11.003_bb0145","article-title":"Severe sepsis: low expression of the renin-angiotensin system is associated with poor prognosis","author":"Zhang","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.110.158220","article-title":"Angiotensin II-mediated microvascular thrombosis","author":"Senchenkova","year":"2010","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.ajem.2021.11.003_bb0155","first-page":"685","article-title":"Angiotensin II brings more questions than answers","volume":"43","author":"Farina","year":"2018","journal-title":"P T"},{"key":"10.1016\/j.ajem.2021.11.003_bb0160","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2019.03.026","article-title":"Angiotensin II in septic shock","author":"Jadhav","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.emc.2019.04.006","article-title":"Emergency department management of acute kidney injury, electrolyte abnormalities, and renal replacement therapy in the critically ill","author":"Co","year":"2019","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.ajem.2021.11.003_bb0180","article-title":"Angiotensin II infusion for shock: a multicenter study of post-marketing use","author":"Wieruszewski","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.ajem.2021.11.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000002441","article-title":"Clinical experience with IV angiotensin II administration: a systematic review of safety","author":"Busse","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0190","doi-asserted-by":"crossref","DOI":"10.1017\/S0266462320000082","article-title":"Angiotensin II for the treatment of distributive shock in the intensive care unit: a US cost-effectiveness analysis","author":"Busse","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0195","doi-asserted-by":"crossref","DOI":"10.5935\/0103-507X.20160079","article-title":"Balanced crystalloids for septic shock resuscitation","author":"Corr\u00eaa","year":"2016","journal-title":"Rev Bras Ter Intensiva"},{"issue":"4","key":"10.1016\/j.ajem.2021.11.003_bb0200","first-page":"311","article-title":"The Protocolised Management in Sepsis (ProMISe) trial statistical analysis plan","volume":"15","author":"Sarah Power","year":"2013","journal-title":"Crit Care Resusc"},{"key":"10.1016\/j.ajem.2021.11.003_bb0205","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201903-0557OC","article-title":"Balanced crystalloids versus saline in sepsis: a secondary analysis of the SMART clinical trial","author":"Brown","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0210","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2015.12334","article-title":"Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial","author":"Young","year":"2015","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.ajem.2021.11.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfs160","article-title":"The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review","author":"Lopes","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ajem.2021.11.003_bb0220","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2017.09.031","article-title":"Vitamin C: the next step in sepsis management?","author":"Teng","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-4804(02)00083-5","article-title":"Ascorbic acid dynamics in the seriously ill and injured","author":"Long","year":"2003","journal-title":"J Surg Res"},{"key":"10.1016\/j.ajem.2021.11.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-12-32","article-title":"Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis","author":"Fowler","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2017.01.008","article-title":"How to give vitamin C a cautious but fair chance in severe sepsis","author":"Oudemans-van Straaten","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ajem.2021.11.003_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-018-2217-4","article-title":"Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation","author":"Moskowitz","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0250","doi-asserted-by":"crossref","DOI":"10.1080\/078538902321117841","article-title":"Markers of inflammation in sepsis","author":"Takala","year":"2002","journal-title":"Ann Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0255","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in sepsis: an updated systematic review and meta-analysis","author":"Rochwerg","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0260","doi-asserted-by":"crossref","DOI":"10.1086\/599343","article-title":"Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis","author":"Sligl","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajem.2021.11.003_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002243.pub3","article-title":"Corticosteroids for treating sepsis","author":"Annane","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajem.2021.11.003_bb0270","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine","author":"Marik","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2017.05.025","article-title":"Vitamin C is not ready for prime time in sepsis but a solution is close","author":"Kalil","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ajem.2021.11.003_bb0280","series-title":"JAMA - Journal of the American Medical Association","article-title":"Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial","author":"Fowler","year":"2019"},{"key":"10.1016\/j.ajem.2021.11.003_bb0285","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-019-2717-x","article-title":"Adjuvant vitamin C for sepsis: mono or triple?","author":"Spoelstra-De Man","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0290","series-title":"JAMA - Journal of the american medical association","article-title":"Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial","author":"Fujii","year":"2020"},{"issue":"1","key":"10.1016\/j.ajem.2021.11.003_bb0295","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.chest.2020.02.049","article-title":"Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis: The ORANGES Trial","volume":"158","author":"Iglesias","year":"2020","journal-title":"Chest."},{"key":"10.1016\/j.ajem.2021.11.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.11946","article-title":"Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial","author":"Moskowitz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2021.11.003_bb0305","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3254-2","article-title":"The vitamin C, thiamine and steroids in sepsis (VICTAS) protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial","author":"Hager","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.ajem.2021.11.003_bb0310","unstructured":"Enrollment has reached 500. 2020:3170."},{"key":"10.1016\/j.ajem.2021.11.003_bb0315","author":"Litwak","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0320","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0000000000002613","article-title":"Vitamin C and thiamine are associated with lower mortality in Sepsis","author":"Byerly","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"10.1016\/j.ajem.2021.11.003_bb0325","first-page":"111","article-title":"Levosimendan: current data, clinical use and future development","volume":"89","author":"Nieminen","year":"2020","journal-title":"Heart Lung Vessel"},{"key":"10.1016\/j.ajem.2021.11.003_bb0330","doi-asserted-by":"crossref","DOI":"10.1097\/00003246-200111000-00022","article-title":"Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock","author":"Oldner","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0335","series-title":"SIMDAX \u00ae (levosimendan)","first-page":"1","author":"Sheet","year":"2009"},{"key":"10.1016\/j.ajem.2021.11.003_bb0340","article-title":"Effects of levosimendan on hemodynamics and cardiac function in patients with septic shock","author":"Fang","year":"2014","journal-title":"Chinese Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0345","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-005-2619-z","article-title":"Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression","author":"Morelli","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2011.06.008","article-title":"The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shock","author":"Memi\u015f","year":"2012","journal-title":"J Crit Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0355","doi-asserted-by":"crossref","DOI":"10.1186\/cc9387","article-title":"Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study","author":"Morelli","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.ajem.2021.11.003_bb0360","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1609409","article-title":"Levosimendan for the prevention of acute organ dysfunction in sepsis","author":"Gordon","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0365","article-title":"The new England journal of medicine: levosimendan in sepsis","author":"Groesdonk","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0370","doi-asserted-by":"crossref","DOI":"10.1177\/0300060519837103","article-title":"Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application","author":"Yang","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ajem.2021.11.003_bb0375","article-title":"Safety of peripheral administration of vasopressor medications: a systematic review","author":"Tian","year":"2020","journal-title":"EMA - Emerg Med Aust"},{"key":"10.1016\/j.ajem.2021.11.003_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/jhm.2394","article-title":"Safety of peripheral intravenous administration of vasoactive medication","author":"Cardenas-Garcia","year":"2015","journal-title":"J Hosp Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0385","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0000000000004445","article-title":"Risk of major complications after perioperative norepinephrine infusion through peripheral intravenous lines in a multicenter study","author":"Pancaro","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajem.2021.11.003_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jemermed.2017.09.007","article-title":"Complications from administration of vasopressors through peripheral venous catheters: an observational study","author":"Medlej","year":"2018","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0395","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-018-5175-z","article-title":"Surviving sepsis campaign: research priorities for sepsis and septic shock","author":"Coopersmith","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0400","doi-asserted-by":"crossref","DOI":"10.4103\/0972-5229.178175","article-title":"Does vasopressin improve the mortality of septic shock patients treated with high-dose NA","author":"Ohsugi","year":"2016","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.ajem.2021.11.003_bb0405","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.528","article-title":"The use of fluids in sepsis","author":"Avila","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.ajem.2021.11.003_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2011.05.006","article-title":"The use of steroids in the treatment of severe sepsis and septic shock","author":"Batzofin","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721009086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721009086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:58:19Z","timestamp":1760025499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721009086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":82,"alternative-id":["S0735675721009086"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.11.003","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}